Slowly expanding lesions are a marker of progressive MS - No.
作者信息
Arnold Douglas L, Belachew Shibeshih, Gafson Arie R, Gaetano Laura, Bernasconi Corrado, Elliott Colm
机构信息
NeuroRx Research, Montreal, QC, Canada/McGill University, Montreal, QC, Canada.
Biogen Digital Health, Biogen, Cambridge, MA, USA.
出版信息
Mult Scler. 2021 Oct;27(11):1681-1683. doi: 10.1177/13524585211017020. Epub 2021 Sep 3.
Abstract
摘要
相似文献
1
Slowly expanding lesions are a marker of progressive MS - No.缓慢扩大的病灶是进展性多发性硬化症的一个标志——否。
Mult Scler. 2021 Oct;27(11):1681-1683. doi: 10.1177/13524585211017020. Epub 2021 Sep 3.
2
Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.慢性白质病变活动可预测原发性进行性多发性硬化症的临床进展。
Brain. 2019 Sep 1;142(9):2787-2799. doi: 10.1093/brain/awz212.
3
Slowly expanding lesions are a marker of progressive MS - Commentary.缓慢扩大的病灶是进展性多发性硬化症的一个标志——评论。
Mult Scler. 2021 Oct;27(11):1683-1685. doi: 10.1177/13524585211040225. Epub 2021 Sep 3.
4
Slowly expanding lesions are a marker of progressive MS - Yes.缓慢扩大的病灶是进展型多发性硬化症的一个标志——是的。
Mult Scler. 2021 Oct;27(11):1679-1681. doi: 10.1177/13524585211013748. Epub 2021 Sep 3.
5
Patterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS Lesions.慢性活动性脱髓鞘在缓慢扩展/演变的多发性硬化症白质病变中的模式。
AJNR Am J Neuroradiol. 2020 Sep;41(9):1584-1591. doi: 10.3174/ajnr.A6742. Epub 2020 Aug 20.
6
Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.作为慢性活动性多发性硬化病变的磁共振成像标志物，病变呈缓慢扩大/演变。
Mult Scler. 2019 Dec;25(14):1915-1925. doi: 10.1177/1352458518814117. Epub 2018 Dec 19.
7
Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.多发性硬化症铁环病变的缓慢扩展：病理学与7T磁共振成像
Acta Neuropathol. 2017 Jan;133(1):25-42. doi: 10.1007/s00401-016-1636-z. Epub 2016 Oct 27.
8
Iron related changes in MS lesions and their validity to characterize MS lesion types and dynamics with Ultra-high field magnetic resonance imaging.铁相关改变在多发性硬化病变及其有效性中的研究：利用超高场磁共振成像对多发性硬化病变类型和动力学进行特征描述。
Brain Pathol. 2018 Sep;28(5):743-749. doi: 10.1111/bpa.12643.
9
Direction and magnitude of displacement differ between slowly expanding and non-expanding multiple sclerosis lesions as compared to small vessel disease.与小血管疾病相比，缓慢扩张和非扩张的多发性硬化病变的位移方向和幅度不同。
J Neurol. 2022 Aug;269(8):4459-4468. doi: 10.1007/s00415-022-11089-9. Epub 2022 Apr 5.
10
Molecular signature of slowly expanding lesions in progressive multiple sclerosis.进展性多发性硬化中缓慢进展病灶的分子特征。
Brain. 2020 Jul 1;143(7):2073-2088. doi: 10.1093/brain/awaa158.
引用本文的文献
1
Associations between chronic active lesions and clinical outcomes in multiple sclerosis: A systematic literature review.多发性硬化症中慢性活动性病变与临床结局的关联：一项系统文献综述。
J Manag Care Spec Pharm. 2025 Jul;31(7):694-721. doi: 10.18553/jmcp.2025.24294. Epub 2025 May 13.
2
A data-driven model of disability progression in progressive multiple sclerosis.一种基于数据驱动的进展性多发性硬化症残疾进展模型。
Brain Commun. 2024 Dec 3;7(1):fcae434. doi: 10.1093/braincomms/fcae434. eCollection 2025.
3
Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance.多发性硬化症中的慢性活动性病变：分类、术语及临床意义
Ther Adv Neurol Disord. 2024 Dec 19;17:17562864241306684. doi: 10.1177/17562864241306684. eCollection 2024.
4
Smouldering Lesion in MS: Microglia, Lymphocytes and Pathobiochemical Mechanisms.多发性硬化症中的潜伏性病灶：小胶质细胞、淋巴细胞和病理生物化学机制。
Int J Mol Sci. 2023 Aug 10;24(16):12631. doi: 10.3390/ijms241612631.
5
B cell depletion therapy does not resolve chronic active multiple sclerosis lesions.B 细胞耗竭疗法不能解决慢性活动性多发性硬化症病灶。
EBioMedicine. 2023 Aug;94:104701. doi: 10.1016/j.ebiom.2023.104701. Epub 2023 Jul 10.
6
Chronic lesion activity and disability progression in secondary progressive multiple sclerosis.继发进展型多发性硬化症的慢性病变活动与残疾进展
BMJ Neurol Open. 2022 Jun 7;4(1):e000240. doi: 10.1136/bmjno-2021-000240. eCollection 2022.
7
Predictive MRI Biomarkers in MS-A Critical Review.MRI 预测生物标志物在 MS 中的应用——批判性综述。
Medicina (Kaunas). 2022 Mar 3;58(3):377. doi: 10.3390/medicina58030377.
本文引用的文献
1
Occurrence and microstructural features of slowly expanding lesions on fingolimod or natalizumab treatment in multiple sclerosis.多发性硬化症中使用芬戈莫德或那他珠单抗治疗时缓慢扩大病变的发生情况及微观结构特征
Mult Scler. 2021 Sep;27(10):1520-1532. doi: 10.1177/1352458520969105. Epub 2020 Nov 13.
2
In vivo imaging of chronic active lesions in multiple sclerosis.多发性硬化症慢性活动性病变的体内成像。
Mult Scler. 2022 Apr;28(5):683-690. doi: 10.1177/1352458520958589. Epub 2020 Sep 23.
3
Patterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS Lesions.慢性活动性脱髓鞘在缓慢扩展/演变的多发性硬化症白质病变中的模式。
AJNR Am J Neuroradiol. 2020 Sep;41(9):1584-1591. doi: 10.3174/ajnr.A6742. Epub 2020 Aug 20.
4
Contribution of Relapse-Independent Progression vs Relapse-Associated Worsening to Overall Confirmed Disability Accumulation in Typical Relapsing Multiple Sclerosis in a Pooled Analysis of 2 Randomized Clinical Trials.在两项随机临床试验的汇总分析中，复发无关进展与复发相关恶化对典型复发型多发性硬化症总体确认残疾累积的贡献。
JAMA Neurol. 2020 Sep 1;77(9):1132-1140. doi: 10.1001/jamaneurol.2020.1568.
5
Chronic white matter lesion activity predicts clinical progression in primary progressive multiple sclerosis.慢性白质病变活动可预测原发性进行性多发性硬化症的临床进展。
Brain. 2019 Sep 1;142(9):2787-2799. doi: 10.1093/brain/awz212.
6
Slowly expanding/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions.作为慢性活动性多发性硬化病变的磁共振成像标志物，病变呈缓慢扩大/演变。
Mult Scler. 2019 Dec;25(14):1915-1925. doi: 10.1177/1352458518814117. Epub 2018 Dec 19.
7
Iron related changes in MS lesions and their validity to characterize MS lesion types and dynamics with Ultra-high field magnetic resonance imaging.铁相关改变在多发性硬化病变及其有效性中的研究：利用超高场磁共振成像对多发性硬化病变类型和动力学进行特征描述。
Brain Pathol. 2018 Sep;28(5):743-749. doi: 10.1111/bpa.12643.
8
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.奥瑞珠单抗与安慰剂治疗原发性进行性多发性硬化症。
N Engl J Med. 2017 Jan 19;376(3):209-220. doi: 10.1056/NEJMoa1606468. Epub 2016 Dec 21.
9
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.对白质多发性硬化斑块动态性质的临床与病理见解。
Ann Neurol. 2015 Nov;78(5):710-21. doi: 10.1002/ana.24497. Epub 2015 Aug 24.
Zotero 插件